Nexstim Plc to present depression led strategy at Investor Conference Sijoittaja 2018 in Helsinki

Helsinki, Finland: 19 September 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), announces that the company will present its new corporate strategy and meet with investors at Sijoittaja 2018 in Helsinki, tomorrow Thursday September 20th.

Mikko Karvinen, Chief Financial Officer, will present on the company and its NBT® System for the treatment of MDD at 12:55 at Messukeskus Helsinki, Expo and Convention Centre.

More info on Nexstim's website.

Next > Mainstay Medical announces 2018 half-year financial results and update

Previous > Sequana Medical announces presentation of pre-clinical proof of concept results of its Direct Sodium Removal (DSR) therapy for the management of volume overload in heart failure at the Annual Scientific Meeting of the Heart Failure Society of America (HFSA)